APRA is forcing the private health insurer to hold an extra $250m in regulatory capital and undergo a technology review.
APRA is forcing the private health insurer to hold an extra $250m in regulatory capital and undergo a technology review.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.